Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04308681
What this trial is testing

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 403
Early research (Phase 1)Study completedNCT06589219
What this trial is testing

Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibroses, Idiopathic
Calibr, a division of Scripps Research 89
Post-approval studies (Phase 4)Study completedNCT03939520
What this trial is testing

Management of Progressive Disease in Idiopathic Pulmonary Fibrosis

Who this might be right for
Progressive Idiopathic Pulmonary Fibrosis
Hospices Civils de Lyon 279
Testing effectiveness (Phase 2)Looking for participantsNCT07194382
What this trial is testing

AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc. 160
Not applicableNot Yet RecruitingNCT07179562
What this trial is testing

Motivational Interviewing Program on the Self-Care in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 124
Not applicableStudy completedNCT03710824
What this trial is testing

Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 180
Not applicableStudy completedNCT03944928
What this trial is testing

ThOracic Ultrasound in Idiopathic Pulmonary Fibrosis Evolution

Who this might be right for
Idiopathic Pulmonary Fibrosis
University Hospital, Tours 30
Not applicableUnknownNCT01499745
What this trial is testing

Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
Rabin Medical Center 40
Not applicableUnknownNCT02827734
What this trial is testing

Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)

Who this might be right for
Pulmonary Healthy ControlsInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis+3 more
Universitätsmedizin Mannheim 50
Testing effectiveness (Phase 2)UnknownNCT05246293
What this trial is testing

Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.

Who this might be right for
Rheumatoid ArthritisInterstitial Lung Disease
National Institute of Respiratory Diseases, Mexico 60
Not applicableUnknownNCT02509364
What this trial is testing

Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF)

Who this might be right for
Interstitial Lung Diseases
Shanghai Pulmonary Hospital, Shanghai, China 300
Early research (Phase 1)Study completedNCT06821464
What this trial is testing

A Trial of HRS-9813 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 45
Not applicableEnded earlyNCT02821039
What this trial is testing

Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study

Who this might be right for
Idiopathic Pulmonary FibrosisUsual Interstitial Pneumonia
Turkish Thoracic Society 1,678
Testing effectiveness (Phase 2)Ended earlyNCT01629667
What this trial is testing

A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
MedImmune LLC 409
Not applicableStudy completedNCT01600352
What this trial is testing

Specific Autoantibody Testing in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease
Singapore General Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT01266135
What this trial is testing

Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT00705133
What this trial is testing

Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial HypertensionInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Rajan Saggar 15
Not applicableLooking for participantsNCT05310669
What this trial is testing

Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Fibrosis, Pulmonary
University of Modena and Reggio Emilia 100
Not applicableStudy completedNCT03300583
What this trial is testing

Toward Self-management in ILD

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisConnective Tissue Related ILD+2 more
Kingston University 16
Testing effectiveness (Phase 2)Study completedNCT02550873
What this trial is testing

A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 117
Next Page